Key facts
- It has raised $150K; the latest was Seed Round in Aug 2025.
- Notable investors include SOSV, IndieBio, HAX, Hong Kong Science & Technology Parks, HK Tech 300 — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Biometallica
- ·The full record, as it builds
Funding rounds
No funding rounds for Biometallica are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biometallica
Developer of a biological metal-recovery process designed for extracting precious metals from waste materials with reduced environmental impact. The company's platform uses engineered microorganisms for biogenic cyanide generation, bioleaching, electrochemical metal reduction, and multi-metal purification, enabling industries handling spent catalysts and electronic waste to recover multiple metals with lower energy use, reduced emissions, and scalable operational capability.
- Sector
- Business Products and Services (B2B)
- HQ
- Singapore, Singapore
- Founded
- 2022
- Employees
- 8
- Website
- biometallica.com/
- Ownership
- Privately Held (backing)
Biometallica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biometallica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biometallica in its N-PORT filings yet. We sweep new filings monthly.